KALA
KALA
NASDAQ · Biotechnology

Kala Bio Inc

$0.17
+0.00 (+0.82%)
Analyst Consensus
Strong Sell
7
Analysts
Moderate
Coverage
Buy 0 0%
Hold 4 57%
Sell 3 43%
Price Target
Analyst Price Target +6,390.7% upside
Low Target $8.32
Average Target $11.19
High Target $14.48
Current Price $0.17
Current
$0.17
Target
$11.19
$8.32 $11.19 avg $14.48
Scenario Analysis
Bear Case
$8.32
4,726.0%
Low target
Base Case
$11.19
+6,390.7%
Avg target
Bull Case
$14.48
+8,299.1%
High target
Risk/Reward
1.8x
Balanced
Price in Context
Target vs 52W High
$11.19
-45.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +18.4%
AMGN
Amgen Inc
Hold 42 50% $190.87 -45.8%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +160.2%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -1.8%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -69.1%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -12.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -28.5%